---
format:
  revealjs:
    theme: [simple, custom.scss]
    transition: fade
    transition-speed: fast
    slide-number: true
    height: 700
    width: 1250
    df-print: paged
    chalkboard: true
    code-fold: show
execute: 
  echo: false
  warning: false
  message: false
editor: visual
---

##  {background-image="Figures/bg2.jpg" visibility="uncounted"}

::: title
**Hemoglobin Evolution In**

**Hemodialysis Patients**
:::

::: author
**Trang Tu - Luong Vuong - Neamin Berhe - Thanh Chuong Cao**
:::

::: date
Longitudinal Data Analysis Project 1
:::

## Study objectives

::: columns
::: {.column width="60%"}


::: {.callout-important icon="false"}
## To investigate:

-   The evolution of hemoglobin (Hgb) over time in hemodialysis patients

-   How this evolution is influenced by EPO dose, iron deficiency status, age, and sex

:::
:::

::: {.column width="5%"}
:::

::: {.column width="35%"}
![](Figures/home-hemodialysis2.jpg){fig-align="right"}
:::
:::

## Methods

### Dataset

-   Longitudinal data of 3823 hemodialysis patients over six months:
    -   Monthly Hgb concentrations
    -   Monthly Erythropoietin (EPO): EPO for the next month was decided by the Hgb level of the current month
    -   Iron deficiency status at each month
    -   Background data: age and sex
-   Unbalanced data: not all patients were follow the whole six months

::: notes
Monthly Hgb measurements and EPO doses
But the data is unbalanced.
:::

## Methods

### Exploratory Data Analyses

-   Individual-specific profiles
-   Graphical methods to explore mean structure, variance structure and correlation structure
-   Test linear and quadratic relationship of each patient' Hgb levels and time: $R^2_{meta}$

::: fragment
### Summary statistics

-   Analysis of each time point: comparison about hemoglobin levels between female and male group at each time point
-   Analysis of increment: subject-specific changes of hemoglobin from baseline ($y_{i1}$) to the last observation ($y_{in_{i}}$): $y_{in_{i}}-y_{i1}$
-   Area under the curve: $$AUC_{i}=(t_{i2}-t_{i1})X(y_{i1}+y_{i2})/2+(t_{i3}-t_{i2})X(y_{i2}+y_{i3})/2+...$$
:::

::: notes
R squared meta-analysis
:::

## Methods

### Multivariate model

-   Initial model, with unstructured covariance: \begin{equation}
    \begin{aligned}
    Y_{ij} &= \beta_{0} + \beta_{1} \, \text{age}_{i} + \beta_{2} \, \text{sex}_{i} + \beta_{3} \, \text{iron}_{ij} + \beta_{4} \, \text{dose}_{ij} + \beta_{5} \, \text{month}_{j} + \beta_{6} \, \text{month}_{j}^{2} \\
         &\quad + \beta_{7} (\text{dose}_{ij} \times \text{age}_{i}) + \beta_{8} (\text{dose}_{ij} \times \text{sex}_{i}) + \beta_{9} (\text{dose}_{ij} \times \text{iron}_{ij}) + \beta_{10} (\text{dose}_{ij} \times \text{month}_{j}) \\
         &\quad + \beta_{11} (\text{month}_{j} \times \text{age}_{i}) + \beta_{12} (\text{month}_{j} \times \text{sex}_{i}) + \beta_{13} (\text{month}_{j} \times \text{iron}_{ij}) + \epsilon_{ij}
    \end{aligned}
    \end{equation}

::: fragment
-   Reduce mean structure: F-test
-   Compare different covariance structures using LR test: unstructured type, simple type, compound symmetry type, banded type, first-order autoregressive type and Toeplitz type
:::

## Methods

### Two-stage analysis model {.smaller .scrollable}

::: columns
::: {.column width="60%"}
::: fragment
#### Stage 1: Linear regression model for each subject separately

$$Y_{ij} = \beta_{1i} + \beta_{2i} t_{ij} + \epsilon_{ij}, \quad j = 0, \dots, 5$$

where:

-   $Y_{ij}$: the hemoglobin measurement for subject $i$ at time $j$.
-   $\beta_{1i}$: intercept for subject $i$
-   $\beta_{2i}$: the slope for subject $i$, showing the rate of change in hemoglobin level per month.
-   $t_{ij}$: the month of observation, measured from 0 to 5.
-   $\epsilon_{ij}$: error term for subject $i$ at time $j$, $\epsilon_{ij} \sim N(0, \sigma^2)$
:::
:::

::: {.column width="40%"}
::: fragment
#### Stage 2: Explain variability in the subject-specific regression coefficients using known covariates

```{=tex}
\begin{equation}
\begin{aligned}
    \beta_{1i} &= \beta_0^{(1)} + \beta_{\text{Age}}^{(1)} \cdot \text{Age}_i + b_{1i} \\
    \beta_{2i} &= \beta_0^{(2)} + \beta_{\text{Age}}^{(2)} \cdot \text{Age}_i + b_{2i}
\end{aligned}
\end{equation}
```
-   $b_{1i}$, $b_{2i}$ are independent and $\sim N(0,D)$
:::
:::
:::

::: notes
Firt we model the linear relationship of each subject's hemoglobin with time
Then we modeled the between-subject variability by examining the effect of age on the intercepts and slopes
:::

## Methods

### Linear mixed model

Four-stage model building process:

#### Step 1: elaborated LMM

```{=tex}
\begin{equation}
\begin{aligned}
Y_i = \beta_0 + \beta_1Age_i + \beta_2Sex_i + \beta_3Dose_{ij} + \beta_4Iron_{ij} + \beta_5t_{ij} + \\
(\beta_6Age_i + \beta_7Sex_i + \beta_7Dose_{ij} + \beta_8Iron_{ij})t_{ij} + \\
(\beta_9Age_i + \beta_{10}Sex_i + \beta_{11}Iron_{ij})Dose_{ij} + \\
  b_{1i} + b_{2j}t_{ij} + \epsilon_{ij}
\end{aligned}
\end{equation}
```
-   $b_{1i}$, $b_{2i} \sim N(0,D)$
-   $\epsilon \sim N(0,\Sigma_i)$

::: fragment
#### Step 2: Adding serial correlation function to residual covariance structure

-   Comprare models with Gaussian serial correlation, exponential serial correlation, and without serial correlation using REML log-likelihood
:::

## Methods

### Linear mixed model

Four-stage model building process:

#### Step 3: Reduce random effect structure

-   Compare model with both random intercept and slope for time with model with only intercept or only slope, using Likelihood ratio test

#### Step 4: Reduce mean structure

-   Compare model from step 3 with models removing interaction effects one by one, using F-test

## Results

### Exploratory Data Analysis

::: columns
::: {.column width="60%"}
-   Individual profiles

![](Results/individual_profile.png)
:::

::: {.column width="10%"}
:::

::: {.column width="30%"}
-   Model assuming a linear relationship between each patient's Hgb and time: $R^2_{meta} = 0.52$
-   Model assuming a quadratic relationship: $R^2_{meta} = 0.73$
-   F-test for addition of quadratic to linear relationship: p \<0.0001
:::
:::

::: notes
The patients have a different Hb at the start of the experiment and this also changes with time.
We modeled individual Hb over time and R squared and F_test suggested that a quadratic relationship with time may explain the data better than linear relationship
:::

## Results

### Exploratory Data Analysis

::: columns
::: {.column width="33%"}
-   Mean structure

![](Results/mean_structure.png)
:::

::: {.column width="33%"}
-   Variance structure

![](Results/var_structure.png)
:::

::: {.column width="34%"}
-   Covariance structure

![](Results/corre-matrix-Hgb.png)
:::
:::

::: notes
The mean Hgb level increases approximately linear over time. 

stable variance over time with an increase in standard error at each time point

the correlation between measurements decreases slightly as two time points are further apart.
:::

## Results

### Summary statistics

::: columns
::: {.column width="\"50%"}
-   Analysis of increments:

![](Results/Hb%20increment.png)
:::

::: {.column width="50%"}
-   Analysis of AUC
    -   $AUC_i$ ranged from -22.5 to 82.4 (mean 42,7, SD 17.8)
    -   Each year increase in age, $AUC_i$ also increased 0.073 (p\<0.001)
    -   No significant effect of sex on AUC
:::
:::

::: notes
Change of Hgb level from baseline to the last measured level varied dramatically.
Majority of patients tended to have minor change in Hgb levels. 
Increase in age leads to increase in AUC. 
Disadvantages: only use partial information so not insightful
:::

## Multivariate model

### Finding parsimonous mean structure

-   Reduce each term and perform F-test against the full model:

| Reduction                               | DF  | F-value | Pr \> F |
|-----------------------------------------|-----|---------|---------|
| *month*$^2$                             | 1   | 1.14    | 0.28    |
| *dose\*sex, dose\*age* and *dose\*iron* | 3   | 1.63    | 0.18    |
| *month\*age* *and month\*sex*           | 5   | 1.95    | 0.08    |
| *month\*iron*                           | 6   | 2.71    | 0.01    |
| *month\*dose*                           | 6   | 6.73    | \<0.001 |

::: notes
multivariate model is a more sophisticated approach to overcome that drawback.

From the full model, we were able to reduce the mean structure by removing some interaction terms. 
:::

## Multivariate model

### Finding appropriate covariance structure

| Covariance structure       | Prameters | -2 Log Likelihood | $G^2$  | df  | p-value |
|------------|------------|------------|------------|------------|------------|
| Unstructured               | 21        | 27693.1           |        |     |         |
| Simple                     | 1         | 32007.9           | 4314.8 | 20  | \<0.001 |
| Compound symmetry          | 2         | 28358.7           | 665.6  | 19  | \<0.001 |
| Banded                     | 21        | 28948.1           | 1255.0 | 0   | \<0.001 |
| First-order autoregressive | 2         | 27755.5           | 62.4   | 19  | \<0.001 |
| Toeplitz                   | 6         | 27735.8           | 42.7   | 15  | 0.002   |

::: notes
The likelihood ratio tests show that the unstructured covariance structure is still superior to other structures
:::

## Multivariate model

### Final model: unstructured covariance structure

-   Effect estimates:

| Effect                 | Estimate | Standard Error | p-value |
|------------------------|----------|----------------|---------|
| Intercept              | 10.61    | 0.09           | \<0.001 |
| Age                    | 0.003    | 0.001          | 0.03    |
| Male                   | 0.10     | 0.04           | 0.008   |
| Iron deficiency        | 0.17     | 0.03           | \<0.001 |
| EPO dose               | 0.0005   | 0.001          | 0.006   |
| Month                  | -0.04    | 0.01           | 0.01    |
| Dose\*month            | 0.0005   | 0.0001         | \<0.001 |
| Iron deficiency\*month | -0.05    | 0.02           | 0.01    |

::: notes
The estimates from the final models suggest that Hemoglobin increase with age, male gender, and EPO dose. The effect of EPO dose increase over time. People with iron deficiency suprisingly have higher Hemoglobin level, but that effect decreases over time. 

Now Luong will continue the presentation.
:::

